Introduction to Biologic and Biosimilar Product Development and Analysis
Introduction to Biologic and Biosimilar Product Development and Analysis
The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies.
Therapeutic Antibodies
Analysis and Regulation of Biologics including Biosimilars.
Recombinant DNA Technology
Therapeutic ProteinsTherapeutic Antibodies
Analysis and Regulation of Biologics including Biosimilars.
Nagel, Karen M.
| ISBN | 978-3-030-07492-0 |
|---|---|
| Medientyp | Buch |
| Copyrightjahr | 2019 |
| Verlag | Springer, Berlin |
| Umfang | XI, 109 Seiten |
| Sprache | Englisch |
